Human medicines European public assessment report (EPAR): Pemetrexed Fresenius Kabi, pemetrexed, Date of authorisation: 22/07/2016, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR): Pemetrexed Accord, pemetrexed, Date of authorisation: 18/01/2016, Revision: 13, Status: Authorised

Agenda - European medicines agencies network strategy (EMANS) to 2028 - webinar

Nilotinib product-specific bioequivalence guidance

Overview of comments received on `Nilotinib hard capsules 50, 150 and 200 mg product-specific bioequivalence guidance’ (EMA/CHMP/518671/2023)

Nilotinib hard capsules 50, 150 and 200 mg product-specific bioequivalence guidance

EMEA-000802-PIP01-09

Herbal medicinal product: Boldi folium, Peumus boldus Molina, C: ongoing call for scientific data

Human medicines European public assessment report (EPAR): Repaglinide Teva, repaglinide, Date of authorisation: 28/06/2009, Revision: 10, Status: Authorised

Executive Steering Group on Shortages and Safety of Medicinal Products